ArticleScientific reports2020

Discovery of a novel fibroblast activation protein (FAP) inhibitor, BR103354, with anti-diabetic and anti-steatotic effects.

Jae Min Cho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.